General Pre-Trial Screening Protocol for Infectious Diseases Research

NCT06463704 · tracked via the Priya Life Science Israel tracker

Sponsor

Beth Israel Deaconess Medical Center

Phase

Observational

Started

2024-06-21

Last updated

2026-04-08

Condition(s) studied

Healthy Volunteers

Investigational drug(s) / intervention(s)

There is no intervention

There is no intervention: There is no intervention

Study summary

The purpose of this general screening protocol is to facilitate recruitment into studies conducted at the Center for Virology and Vaccine Research (CVVR) or Division of Infectious Diseases at Beth Israel Deaconess Medical Center. This general screening protocol will help to determine the eligibility of potential volunteers for any vaccine or therapeutic trials open for recruitment or soon to be opened.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * 18 years of age or older at time of consent * Available to participate for the planned duration of the clinical trials for which screening is being done * Capable of giving signed informed consent Exclusion Criteria: • A condition, based on clinical judgement, which requires active medical intervention or monitoring to avert serious danger to the participant's health or well-being

Primary outcome measure(s)

Distribution of demographic variables — At enrollment
Race, ethnicity, gender and sex at birth
Number of participants who subsequently enroll in another study — From date of enrollment until the date of enrollment in a subsequent study or up to 52 weeks, whichever comes first
The number of participants in the general screening protocol who go on to enroll in another study

Trial sites (1)

Facility	City	Region	Status
Beth Israel Deaconess Medical Center	Boston	Massachusetts	Recruiting

More Beth Israel Deaconess Medical Center trials in Israel

Pain Control for Cervical Ripening Balloon Recruiting

Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana Active, not recruiting

Mechanical Ventilator Adjustments and Patient Dyspnea Starting soon

Prospective Validation of an EHR-based Pancreatic Cancer Risk Model Active, not recruiting

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy Recruiting

Other trials for the same condition

Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers Recruiting

Pilot Clinical Trial of Ultrasound Guided Aortic Compression for Arresting Abdominal Aortic Blood Flow in Healthy Volunteers. This Isn't Device Feasibility, But Rather the Feasibility of a Clinical Maneuver; Specifically, Evaluating Whether the Technique Can Achieve the Anticipated Out Starting soon

Determination of Physical Parameters Relevant to Ophthalmic Lasers Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06463704 on ClinicalTrials.gov ↗ ← All trials in Israel